FsTech List of Products and Services

This article introduces the research and development of a ventricular assist device conducted by researchers at the Penn State College of Medicine using CAESES and CONVERGE. The goal of this research is to reduce the risk of adverse events such as hemolysis, degradation of von Willebrand factor, and thrombosis while minimizing the size of the pumps used in artificial hearts. To efficiently create a wide range of pump designs, CAESES has parameterized the flow path shape of the pump. *For more detailed information, you can view the related links. For further details, please download the PDF or feel free to contact us.*

Cardiovascular diseases are a leading cause of death worldwide, but recent advances in medical technology are allowing many people suffering from heart conditions and injuries to gain a new lease on life. The ventricular assist devices (VADs) relevant to this case are mechanical circulatory support devices that replace the function of a failing heart by pumping blood from the heart's lower chambers (ventricles) into the aorta. There are various types of VADs, including volume pumps that mimic natural heartbeats and continuous flow pumps for patients without a heartbeat. Other differences include the type of pump, such as centrifugal or axial flow, the placement of the pump, and which ventricle is being assisted (right - RVAD, left - LVAD, or both - BiVAD). *For more detailed information, please refer to the related links. For further details, you can download the PDF or feel free to contact us.*